Results 101 to 110 of about 2,428 (197)
Autosomal recessive polycystic kidney disease (ARPKD) is a severe pediatric hepatorenal disorder with pronounced phenotypic variability. A substantial number of patients with early diagnosis reaches adulthood and some patients are not diagnosed until ...
Kilian, Samuel +23 more
core +1 more source
Charakterisierung der Interaktion zwischen dem Usher-Syndrom-Protein Harmonin und dem ARPKD-Zystennierenprotein Polyductin [PDF]
Cilia are hair-like structures that extend from the surface of epithelial cells. Human diseases referred to as ciliopathies arise from defects in cilia function. Autosomal recessive polycystic kidney disease (ARPKD), the most frequent cause of hereditary
Mager, Silke
core +1 more source
Autosomal recessive polycystic kidney disease (ARPKD) is an important cause of renal- and liver related morbidity and mortality in neonates and infants, occurring 1 in 20000-40000 live births.
Küpper, Marc Fabian
core
Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a genetic disorder with an incidence of ~1:20,000 that manifests in a wide range of renal and liver disease severity in human patients and can lead to perinatal mortality.
Hilton, H +8 more
core
Autosomal recessive polycystic kidney disease (ARPKD) is a form of hereditary cystic disease with a highly variable phenotypic expression that ultimately leads to chronic kidney disease.
Ana Nevarez Gilbert +2 more
doaj +1 more source
Modeling Complex Developmental Disease: The Case of Polycystic Kidney Disease. [PDF]
DeLoriea J +5 more
europepmc +1 more source
Biallelic PKD1 mutations causing neonatal death in an extremely preterm infant: a Korean case report of very early-onset ADPKD. [PDF]
Lee DH, Park J, Kim HH, Kim JK.
europepmc +1 more source
Scoping Review on Polycystic Liver Disease in PKD1/PKD2 Gene Carriers: Genetic Aspects, Pathophysiology, and Therapeutic Approaches. [PDF]
Muñoz-Delgado DY +5 more
europepmc +1 more source
Congenital hepatic fibrosis and related ciliopathies across the life course: current management, disease burden, and unmet needs in the era of genomic diagnosis and translational therapeutics. [PDF]
Wang A, He J, Liu K, Fu J, Chen J.
europepmc +1 more source

